David Epstein
Fundador en BLACK DIAMOND THERAPEUTICS, INC. .
Fortuna: 5 M $ al 30/04/2024
Cargos activos de David Epstein
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/09/2016 | - |
| Fundador | 01/01/2014 | - | |
| Director Ejecutivo | 01/09/2016 | 15/09/2023 | |
| Presidente | 01/09/2016 | 15/09/2023 |
Historial de carrera de David Epstein
Antiguos cargos conocidos de David Epstein.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| METASTAT, INC. | Director/Miembro de la Junta | 16/04/2013 | 01/04/2015 |
| Corporate Officer/Principal | 16/04/2013 | 01/04/2015 | |
| OSI PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 07/04/2010 | 31/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
| Fundador | 01/05/2001 | 01/01/2003 | |
| Corporate Officer/Principal | 01/05/2001 | 01/01/2003 | |
| Duke-NUS Graduate Medical School Singapore | Corporate Officer/Principal | - | - |
Formación de David Epstein.
| Lewis & Clark College (Oregon) | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Singapur | 2 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- David Epstein
- Experiencia